TABLE 3.
Medication regimen or type | No. of children | % | No. of prescriptions | % |
---|---|---|---|---|
Medication regimen | ||||
Inhaled corticosteroid alone | 1 | 6 | ||
Bronchodilator with inhaled corticosteroid | 10 | 59 | ||
Bronchodilator with (inhaled corticosteroid or combination drug*) and with oral steroid | 6 | 35 | ||
Medication type† | ||||
Brand-name bronchodilator | 5 | 10 | ||
Generic bronchodilator | 17 | 33 | ||
Brand-name inhaled corticosteroid | 21 | 40 | ||
Generic inhaled corticosteroid | 0 | 0 | ||
Brand-name combination drug* | 2 | 4 | ||
Oral steroid | 6 | 12 | ||
Brand-name leukotriene antagonist | 1 | 2 |
Combination drug combines a long-acting β-agonist with an inhaled corticosteroid in a singe inhaler.
Based on 52 prescriptions reported in 17 respondents.